233 related articles for article (PubMed ID: 11796625)
1. In vitro and in vivo interactions of Haemophilus ducreyi with host phagocytes.
Ahmed HJ; Johansson C; Svensson LA; Ahlman K; Verdrengh M; Lagergård T
Infect Immun; 2002 Feb; 70(2):899-908. PubMed ID: 11796625
[TBL] [Abstract][Full Text] [Related]
2. The role of Haemophilus ducreyi bacteria, cytotoxin, endotoxin and antibodies in animal models for study of chancroid.
Lagergård T
Microb Pathog; 1992 Sep; 13(3):203-17. PubMed ID: 1291843
[TBL] [Abstract][Full Text] [Related]
3. Interactions of the Skin Pathogen
Brothwell JA; Griesenauer B; Chen L; Spinola SM
Front Immunol; 2020; 11():615402. PubMed ID: 33613541
[TBL] [Abstract][Full Text] [Related]
4. Haemophilus ducreyi inhibits phagocytosis by U-937 cells, a human macrophage-like cell line.
Wood GE; Dutro SM; Totten PA
Infect Immun; 2001 Aug; 69(8):4726-33. PubMed ID: 11447144
[TBL] [Abstract][Full Text] [Related]
5. Immune cells are required for cutaneous ulceration in a swine model of chancroid.
San Mateo LR; Toffer KL; Orndorff PE; Kawula TH
Infect Immun; 1999 Sep; 67(9):4963-7. PubMed ID: 10456960
[TBL] [Abstract][Full Text] [Related]
6. A temperature-dependent rabbit model for production of dermal lesions by Haemophilus ducreyi.
Purcell BK; Richardson JA; Radolf JD; Hansen EJ
J Infect Dis; 1991 Aug; 164(2):359-67. PubMed ID: 1856485
[TBL] [Abstract][Full Text] [Related]
7. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
8. Characterization of skin lesions in mice following intradermal inoculation of Haemophilus ducreyi.
Tuffrey M; Alexander F; Ballard RC; Taylor-Robinson D
J Exp Pathol (Oxford); 1990 Apr; 71(2):233-44. PubMed ID: 2331407
[TBL] [Abstract][Full Text] [Related]
9. The Haemophilus ducreyi LspA1 protein inhibits phagocytosis by using a new mechanism involving activation of C-terminal Src kinase.
Dodd DA; Worth RG; Rosen MK; Grinstein S; van Oers NS; Hansen EJ
mBio; 2014 May; 5(3):e01178-14. PubMed ID: 24902122
[TBL] [Abstract][Full Text] [Related]
10. A humoral immune response confers protection against Haemophilus ducreyi infection.
Cole LE; Toffer KL; Fulcher RA; San Mateo LR; Orndorff PE; Kawula TH
Infect Immun; 2003 Dec; 71(12):6971-7. PubMed ID: 14638786
[TBL] [Abstract][Full Text] [Related]
11. Role of lipooligosaccharides in experimental dermal lesions caused by Haemophilus ducreyi.
Campagnari AA; Wild LM; Griffiths GE; Karalus RJ; Wirth MA; Spinola SM
Infect Immun; 1991 Aug; 59(8):2601-8. PubMed ID: 1855979
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of phagocytosis by Haemophilus ducreyi requires expression of the LspA1 and LspA2 proteins.
Vakevainen M; Greenberg S; Hansen EJ
Infect Immun; 2003 Oct; 71(10):5994-6003. PubMed ID: 14500520
[TBL] [Abstract][Full Text] [Related]
13. Interactions of Haemophilus ducreyi and purified cytolethal distending toxin with human monocyte-derived dendritic cells, macrophages and CD4+ T cells.
Xu T; Lundqvist A; Ahmed HJ; Eriksson K; Yang Y; Lagergård T
Microbes Infect; 2004 Nov; 6(13):1171-81. PubMed ID: 15488736
[TBL] [Abstract][Full Text] [Related]
14. Immunization with the Haemophilus ducreyi hemoglobin receptor HgbA protects against infection in the swine model of chancroid.
Afonina G; Leduc I; Nepluev I; Jeter C; Routh P; Almond G; Orndorff PE; Hobbs M; Elkins C
Infect Immun; 2006 Apr; 74(4):2224-32. PubMed ID: 16552053
[TBL] [Abstract][Full Text] [Related]
15. Haemophilus ducreyi partially activates human myeloid dendritic cells.
Banks KE; Humphreys TL; Li W; Katz BP; Wilkes DS; Spinola SM
Infect Immun; 2007 Dec; 75(12):5678-85. PubMed ID: 17923525
[TBL] [Abstract][Full Text] [Related]
16. Swine model of Haemophilus ducreyi infection.
Hobbs MM; San Mateo LR; Orndorff PE; Almond G; Kawula TH
Infect Immun; 1995 Aug; 63(8):3094-100. PubMed ID: 7622236
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical investigations of genital ulcers caused by Haemophilus ducreyi.
Abeck D; Freinkel AL; Korting HC; Szeimis RM; Ballard RC
Int J STD AIDS; 1997 Sep; 8(9):585-8. PubMed ID: 9292349
[TBL] [Abstract][Full Text] [Related]
18. The cytolethal distending toxin of Haemophilus ducreyi aggravates dermal lesions in a rabbit model of chancroid.
Wising C; Mölne L; Jonsson IM; Ahlman K; Lagergård T
Microbes Infect; 2005 May; 7(5-6):867-74. PubMed ID: 15876546
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of skin adherence, penetration and tissue necrosis production by Haemophilus ducreyi, the causative agent of chancroid.
Abeck D; Korting HC
Acta Derm Venereol Suppl (Stockh); 1992; 174():1-20. PubMed ID: 1636361
[TBL] [Abstract][Full Text] [Related]
20. Haemophilus ducreyi targets Src family protein tyrosine kinases to inhibit phagocytic signaling.
Mock JR; Vakevainen M; Deng K; Latimer JL; Young JA; van Oers NS; Greenberg S; Hansen EJ
Infect Immun; 2005 Dec; 73(12):7808-16. PubMed ID: 16299270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
